Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPT-CAD Score Guided DAPT De-escalation in ACS
NCT06216821Recruiting
- Sponsor
- General Hospital of the Northern Theater Command
- Start
- Jul 2024
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Randomised trial in acute coronary syndrome (ACS) (2 arms), sponsored by General Hospital of the Northern Theater Command. Primary endpoint: Net adverse clinical events at 12 months. Started Jul 2024; status: recruiting.
02
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT06216821.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06216821.